MIT Introduces MagMix to Reduce Cell Settling in 3D Bioprinting, Addresses Key Limitation
Researchers at the Massachusetts Institute of Technology (MIT) have created MagMix, a compact magnetic system that actively prevents cell settling during 3D bioprinting, producing more uniform and functional tissues. The innovation addresses a key limitation in biofabrication: sedimentation in bioinks—a mixture of living cells and hydrogels—which can cause clogging, uneven cell distribution, and inconsistent tissue quality, making it difficult to print large or complex tissues reliably.